%0 Journal Article
%T Unlocking the intricacies: Exploring the complex interplay between platelets and ovarian cancer.
%A Xie Q
%A Zhou J
%A He C
%A Xu Y
%A Tao F
%A Hu M
%J Crit Rev Oncol Hematol
%V 202
%N 0
%D 2024 Oct 2
%M 39097249
%F 6.625
%R 10.1016/j.critrevonc.2024.104465
%X Ovarian cancer, an aggressive malignancy of the female reproductive tract, is frequently linked to an elevated risk of thrombotic events. This association is manifested by a pronounced rise in platelet counts and activation levels. Current research firmly supports the pivotal role of platelets in the oncogenic processes of ovarian cancer, influencing tumor cell proliferation and metastasis. Platelets influence these processes through direct interactions with tumor cells or by secreting cytokines and growth factors that enhance tumor growth, angiogenesis, and metastasis. This review aims to thoroughly dissect the interactions between platelets and ovarian cancer cells, emphasizing their combined role in tumor progression and associated thrombotic events. Additionally, it summarizes therapeutic strategies targeting platelet-cancer interface which show significant promise. Such approaches could not only be effective in managing the primary ovarian tumor but also play a pivotal role in preventing metastasis and attenuating thrombotic complications associated with ovarian cancer.